Neil Bifulco, Jr

Title: Neil Bifulco, Jr.: Innovator in Pharmaceutical Chemistry

Introduction

Neil Bifulco, Jr. is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Bifulco's latest patents include innovative compounds that serve as pharmaceutical agents. The first patent focuses on 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors. This invention provides compounds and compositions that can be utilized in the preparation and application of these agents. The second patent involves CCR5 antagonists as therapeutic agents. This invention relates to compounds that are useful in the treatment and prophylaxis of CCR5-related diseases, including the inhibition of HIV replication and the treatment of acquired immune deficiency syndrome (AIDS).

Career Highlights

Throughout his career, Neil Bifulco, Jr. has worked with prominent companies in the pharmaceutical industry. He has been associated with SmithKline Beecham Corporation and GlaxoSmithKline LLC, where he contributed to various research and development projects. His expertise in pharmaceutical chemistry has allowed him to make significant advancements in drug development.

Collaborations

Bifulco has collaborated with several professionals in his field, including Wieslaw Mieczyslaw Kazmierski and Christopher Joseph Aquino. These collaborations have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Neil Bifulco, Jr. is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic agents. His contributions continue to influence the treatment of critical health issues, showcasing the impact of innovation in the medical field.